Navigation Links
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Date:8/19/2007

SEATTLE, Aug. 17 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced publication of results from a Phase 1 study of NEUVENGE, an investigational active cellular immunotherapy, in the August 20 issue of the Journal of Clinical Oncology. The article highlights the safety profile, immune response and clinical activity of NEUVENGE in women with HER2/neu-positive breast cancer who have failed standard therapy.

"In addition to demonstrating that NEUVENGE was safe and well tolerated, the T-cell responses seen in these patients and the prolonged disease stabilization in the absence of other anti-cancer therapies in many patients is promising," said John W. Park, M.D., associate clinical professor of medicine and neurosurgery at the University of California, San Francisco and lead author of the publication. "These observations are encouraging and are suggestive of the clinical benefit of NEUVENGE, particularly in light of the aggressive cancer seen in these patients who had progressed while on standard therapy. The findings warrant additional studies of NEUVENGE for the many women with advanced breast cancer who have exhausted many of their treatment options."

Study Design

The Phase 1 study (D2000-2) was conducted to evaluate the safety and immunologic activity of NEUVENGE in patients with HER2-overexpressing metastatic breast cancer who had failed standard therapy, including prior treatment with chemotherapy and trastuzumab. All patients had experienced disease progression while on standard therapy. There were 19 patients enrolled in the study with 18 patients receiving treatment with NEUVENGE. Patients underwent three infusions of NEUVENGE at Weeks 0, 2, and 4 following randomizati
'/>"/>

SOURCE Dendreon Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...REYKJAVIK,Iceland,November24/PRNewswire-FirstCall/...dthatithasreceivednoticefrom,theNasdaqStockMarkett...dasofNovember30,2009andaForm25-NSEwillbefiledwitht...deCODE,scommonstock,fromlistingonNasdaq,unlessthec...nsPanel.Thecompanyhasfiledsuchanappeal,which,wills...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceutica...O)hasallowedthepatentapplicationfor,itsnano-partic...yisahighlyefficientapproachtoincorporatepeptidesor...ldeliveryofdrugs,otherwiseadministeredasinjections...edtomanymacromoleculardrugssuchasinsulin,interfero...
(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxya...n(SFDA)hasapprovedthe,investigationalnewdrugapplic...vativeinsulinformulationtotreatdiabetes.ThisIND,ap...lstudy. , Diabetesisadisordercharacteristicof...sofdiabetesoftenresultinseveremicro-and,macro-vasc...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...CALGARY, Oct. 3 /PRNewswire-FirstCall/ - Dr. Brad ...Inc. (TSX: ONC, NASDAQ: ONCY), will present a,corp...ioPartnering Europe,conference in London, U.K. on ...e held at the Queen Elizabeth II Conference Centre...Inc. Oncolytics is a Calgary-based biotechnology ...
...NEW CANAAN, Conn., Oct. 3 Marshall Edwards,Inc. (...orum 2007 at the San,Francisco Palace Hotel on Thu...ll Edwards, Inc. Marshall Edwards, Inc. (Nasdaq: ...n the clinical development of novel anti-cancer th...gy platform which has generated a,number of novel ...
...,Collaboration, Key to Success, EL SEGUNDO, Calif...eaders" have specific characteristics that positio... fifth annual Global Survey of,Supply Chain Progre...),Supply Chain Management Review and Michigan Stat...y chain professionals in 21 industries,identifies ...
Other Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 32007 Global Survey Identifies Characteristics of Supply Chain Leaders 22007 Global Survey Identifies Characteristics of Supply Chain Leaders 32007 Global Survey Identifies Characteristics of Supply Chain Leaders 4
(Date:11/25/2009)..., Athens, Ga. Bacteria don,t have easy lives. In... the bugs, they have natural enemies called bacter...arth every two days. , Still, bacteria and anot...discovered in extreme environments such as deep-se...part because they have a built-in defense system t...
(Date:11/25/2009)..., Two Kent State University assistant professors ...e Foundation (NSF) to continue research beneficial...s total $890,000. , Christopher Blackwood, assis...ences, was awarded grants to support two separate ...Assembling Litter Decomposer Communities and Funct...
(Date:11/24/2009)..., Scientists have crystallised a protein that may...act. The protein could be used by probiotic produc...eal benefit to people. , "Probiotics need to inte...l effect, and if they attach to surfaces in the gu... to exert their activity," says Dr Nathalie Juge f...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2Scientists learn why even treated genital herpes sores boost the risk of HIV infection 53432 1Scientists learn why even treated genital herpes sores boost the risk of HIV infection 53432 2Scientists learn why even treated genital herpes sores boost the risk of HIV infection 53432 3Scientists learn why even treated genital herpes sores boost the risk of HIV infection 53432 4Stem cell daughters lead to breast cancer 9453 1Stem cell daughters lead to breast cancer 9453 2US Discount Online Pharmacy Expressdelivery biz Can Guarantee Safe and Enjoyable Shopping Experience With buySAFE Certificate 53429 1US Discount Online Pharmacy Expressdelivery biz Can Guarantee Safe and Enjoyable Shopping Experience With buySAFE Certificate 53429 2
...ADISON, WI, OCTOBER 20, 2008 -- The widespread use...n practice for decades, with little knowledge of t... , The results of a new study show that samples ...etained a high concentration of pesticide contamin...y to assess the extent of the impact of contaminan...
...ritz et al. have identified an amino acid switch t...aviviruses such as tick-borne encephalitis virus (...n pathogens. These membrane-encircled viruses ente...ing their membrane with that of the endosome., Fus...ent. Low pH prompts the aptly named fusion protein...
...T. LOUIS -- Researchers are one step closer to fin...ulosis. An investigational vaccine for TB tested a...ignificantly better protection against the potenti... "Not only was it as safe as the standard vaccine,...ts it will be more effective at protecting against...
Other Biology News:Pesticide concentrations decreasing 2Research identifies type of vaccine that holds promise in protecting against TB 2
Mouse Anti-C1-inhibitor (C1-INH) Monoclonal Antibody, Unconjugated, Clone 8F3 from AntibodyShop A/S
...Certify products ATP-Free using Mo Bio luciferase ...ive ATP-Free certification service that will allow... level of accuracy and enable you to deliver them ... detection limit is 3.5 x 10-12 /l, which will all...
Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
...Small Molecule Localization in Early Drug Developm...al drug compound localization data in early drug d...erys imaging mass spectrometry service maps unlab...s so you can localize drugs and metabolites prior ...
Biology Products: